Man Group Portfolio holdings
AUM
$46.3B
1-Year Return
20.09%
This Quarter Return
+28.25%
1 Year Return
+20.09%
3 Year Return
+87.95%
5 Year Return
+152.77%
10 Year Return
–
AUM
$19.8B
AUM Growth
+$4.41B
(+29%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
16.82%
Holding
1,884
New
324
Increased
583
Reduced
656
Closed
225
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$223M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
Microsoft
MSFT
|
+$142M |
| 4 |
Bank of New York Mellon
BK
|
+$108M |
| 5 |
Dollar General
DG
|
+$98.3M |
Top Sells
| 1 |
Amazon
AMZN
|
+$145M |
| 2 |
Morgan Stanley
MS
|
+$107M |
| 3 |
IQVIA
IQV
|
+$72.6M |
| 4 |
Incyte
INCY
|
+$68.4M |
| 5 |
New Oriental
EDU
|
+$66M |
Sector Composition
| 1 | Technology | 24.34% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Financials | 12.46% |
| 5 | Consumer Staples | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Tractor Supply
TSCO
$31.1B
| $8.81M | 0.04% |
334,295
+32,895
| +11% | +$867K |
|
|
AMED
377
DELISTED
Amedisys
AMED
| $8.79M | 0.04% |
44,251
-69,733
| -61% | -$13.8M |
|
378
Cintas
CTAS
$81B
| $8.78M | 0.04% |
131,840
+5,552
| +4% | +$370K |
|
|
BPMC
379
DELISTED
Blueprint Medicines
BPMC
| $8.75M | 0.04% |
112,232
+33,880
| +43% | +$2.64M |
|
380
Natera
NTRA
$23.3B
| $8.74M | 0.04% |
175,340
+39,259
| +29% | +$1.96M |
|
381
NXP Semiconductors
NXPI
$56.1B
| $8.74M | 0.04% |
76,641
-236,599
| -76% | -$27M |
|
|
ARNA
382
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.74M | 0.04% |
138,792
-113,480
| -45% | -$7.14M |
|
|
STMP
383
DELISTED
Stamps.com, Inc.
STMP
| $8.73M | 0.04% |
+47,511
| New | +$8.73M |
|
384
Alnylam Pharmaceuticals
ALNY
$61.5B
| $8.72M | 0.04% |
58,884
+56,184
| +2,081% | +$8.32M |
|
385
Bio-Techne
TECH
$8.23B
| $8.7M | 0.04% |
131,816
+48,456
| +58% | +$3.2M |
|
386
lululemon athletica
LULU
$19.5B
| $8.7M | 0.04% |
27,881
-27,864
| -50% | -$8.69M |
|
387
Genworth Financial
GNW
$3.51B
| $8.68M | 0.04% |
3,759,128
+1,432,633
| +62% | +$3.31M |
|
|
FVAC.U
388
DELISTED
Fortress Value Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FVAC.U
| $8.68M | 0.04% |
+842,941
| New | +$8.68M |
|
389
Fidelity National Information Services
FIS
$35B
| $8.65M | 0.04% |
64,523
-13,247
| -17% | -$1.78M |
|
390
Generac Holdings
GNRC
$10.8B
| $8.64M | 0.04% |
70,884
+29,734
| +72% | +$3.63M |
|
391
Enanta Pharmaceuticals
ENTA
$190M
| $8.55M | 0.04% |
170,324
-26,281
| -13% | -$1.32M |
|
392
Philip Morris
PM
$257B
| $8.5M | 0.04% |
121,336
-36,913
| -23% | -$2.59M |
|
393
Bank of America
BAC
$372B
| $8.49M | 0.04% |
357,305
-103,088
| -22% | -$2.45M |
|
394
Equinix
EQIX
$77.3B
| $8.48M | 0.04% |
12,081
-19,838
| -62% | -$13.9M |
|
395
National Beverage
FIZZ
$3.63B
| $8.48M | 0.04% |
278,048
+17,196
| +7% | +$525K |
|
396
CrowdStrike
CRWD
$107B
| $8.47M | 0.04% |
84,477
+78,365
| +1,282% | +$7.86M |
|
397
Twilio
TWLO
$16.3B
| $8.45M | 0.04% |
38,499
-15,253
| -28% | -$3.35M |
|
398
Medifast
MED
$151M
| $8.44M | 0.04% |
60,801
-34,399
| -36% | -$4.77M |
|
399
BCE
BCE
$22.5B
| $8.42M | 0.04% |
202,428
-275,489
| -58% | -$11.5M |
|
400
Apellis Pharmaceuticals
APLS
$3.32B
| $8.41M | 0.04% |
257,346
+244,384
| +1,885% | +$7.98M |
|